A Systematic Review of Sequencing and Combinations of Systemic Therapy in Metastatic Renal Cancer

noticia |

Albiges L., Choueiri T., Escudier B., Galsky M., George D., Hofmann F., Lam T., Motzer R., Mulders P., Porta C., Powles T., Sternberg C., Bex A.

European Urology 2014 

Context: The introduction of novel molecular-targeted agents has revolutionised the management of patients with metastatic renal cell carcinoma (mRCC). However, uncertainties remain over sequential or simultaneous combination therapies. Objective: To systematically review relevant literature comparing the clinical effectiveness and harms of different sequencing and combinations of systemic targeted therapies for mRCC. Evidence acquisition: Relevant databases (including Medline, Cochrane Library, trial registries, and conference proceedings) were searched (January 2000 to September 2013) including only randomised controlled trials (RCTs). Risk of bias assessment was performed. A qualitative and quantitative synthesis of the evidence was presented. Evidence synthesis: The literature search identified 5149 articles. A total of 24 studies reporting on 9589 patients were eligible for inclusion; data from four studies were included for meta-analysis. There were generally low risks of bias across studies; however, clinical and methodological heterogeneity prevented pooling of data for most studies…(vermás)


1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)